Azura Ophthalmics receives grant for leading CLD clinical candidate
September 10th 2022Azura has secured funding to support its 2-stage study evaluating the safety, tolerability, and efficacy of AZR-MD-001, its leading candidate, for patients with contact lens discomfort who show signs of meibomian gland dysfunction.